You called it!

Definitely an upward move.

Looking at the difference between yesterday's volume and today's makes me wonder...

It could've been some random investor placing his bet on the likelihood of this thing working out.

10 million shares isn't that much in terms of cash. It's not like 10 million shares of a $100 stock.

So the $120 million payment is coming after Phase 2, right?

Would anyone care to estimate when that is?

CTIX isn't an ADR.

It's one and only listing in the world is OTC.

That's why it has 0% institutional ownership.

Why does it surprise you that it's "under the radar"?

It's OTC!

Institutions can't touch it and most investors won't even look at OTC stocks.

Personally, I swore off OTC stocks a long tome ago because they were free to make up stories and not suffer any consequences.

CTIX is a big exception for me.

Most investors aren't willing to make that exception.

Now, watch what happens when this thing hits the Nasdaq

DOH!!!

TLD NEJ?

What exactly do you want him to do?

This stock is worth zero if it can't get its products approved by the FDA.

We're still in Phase 2 for 2014.

After Phase 3 is when things take off.

Look at the chart on any biotech.

When did it go vertical? After Phase 3 approval.

Because they need cash?

And maybe Pfizer isn't chomping at the bit to give it to them?

Intel's getting serious about wearable computing.


"He said Intel will be partnering with the luxury retailer Barneys New York, the Council of Fashion Designers of America and design house Opening Ceremony to explore and market smart wearable technology."


http://gulfnews.com/business/technology/intel-takes-leap-into-wearable-computing-1.1275041

I'm really not enthusiastic about selling at this point.

After Phase 2---OK let's talk.

But the company's in a position of weakness right now.

Not a good time to put up a For Sale sign.

Well, you shouldn't make investment decisions based on one man.

He could get eaten by a grizzly bear tomorrow.

The fact is that this company has some important patents and collaborations going on.

VPHM?

The challenge is surviving the course.

It's always different this time with MVIS, right?

All this hype is great, but don't you think we're range bound under 2.40 until Phase 3 is a done deal?